Expertise in
4
conditions

Dr. David Fitz-Patrick

Endocrinology
David Fitz-Patrick MD Inc.
1585 Kapiolani Blvd Ste 1500, 
Honolulu, HI 
Accepting New Patients
Offers Telehealth
Referral required
Before you request
Expertise in
4
conditions
David Fitz-Patrick MD Inc.
1585 Kapiolani Blvd Ste 1500, 
Honolulu, HI 

Overview

David Fitz-Patrick is an Endocrinologist practicing medicine in Honolulu, Hawaii.

Dr. Fitz-Patrick is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Prolactinoma, and Pituitary Tumor.

He is actively involved in clinical research, co-authoring 19 peer reviewed articles and participating in 11 clinical trials. Dr. Fitz-Patrick is currently accepting new patients.

Specialties

Endocrinology

Licenses

Specialist in HI

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AlohaCare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Hawaii Medical Assurance Association
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PacificSource
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

David Fitz-Patrick MD Inc.
1585 Kapiolani Blvd Ste 1500, Honolulu, HI 96814

Additional Areas of Focus

Dr. Fitz-Patrick has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
Enrollment Status: Completed
Publish Date: July 14, 2026
Intervention Type: Other
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Enrollment Status: Completed
Publish Date: July 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
Enrollment Status: Completed
Publish Date: May 22, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
An Assessment of the Impact of an App Based Diabetes Training Program in Conjunction With the Use of BD Nano 2nd Gen 4mm Pen Needle on Diabetes Self-efficacy in People With Type 2 Diabetes
An Assessment of the Impact of an App Based Diabetes Training Program in Conjunction With the Use of BD Nano 2nd Gen 4mm Pen Needle on Diabetes Self-efficacy in People With Type 2 Diabetes
Enrollment Status: Terminated
Publish Date: July 08, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
A Phase 2, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
Enrollment Status: Completed
Publish Date: March 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Enrollment Status: Completed
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Patient and Investigator Blinded, Placebo Controlled, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With Non-alcoholic Steatohepatitis (NASH)
A Randomized, Patient and Investigator Blinded, Placebo Controlled, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With Non-alcoholic Steatohepatitis (NASH)
Enrollment Status: Terminated
Publish Date: January 05, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: June 12, 2020
Intervention Type: Drug
Study Phase: Phase 3
Comparative User Experiences With BD Nano™ PRO 4mm x 32G Extra Thin Wall Pen Needle vs the Artsana Insupen® Extr3me 4mm x 33G, Artsana Insupen® Extr3me 3.5mm x 34G and the Simple Diagnostics Comfort EZ™ 4mm x 33G Pen Needles
Comparative User Experiences With BD Nano™ PRO 4mm x 32G Extra Thin Wall Pen Needle vs the Artsana Insupen® Extr3me 4mm x 33G, Artsana Insupen® Extr3me 3.5mm x 34G and the Simple Diagnostics Comfort EZ™ 4mm x 33G Pen Needles
Enrollment Status: Completed
Publish Date: March 09, 2020
Intervention Type: Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

19 Total Publications

Phase 3 Randomized Study Investigating the Safety, Tolerability, and Immunogenicity of a Combination Modified Messenger RNA Vaccine Against Influenza and COVID-19 in Healthy Adults.
Phase 3 Randomized Study Investigating the Safety, Tolerability, and Immunogenicity of a Combination Modified Messenger RNA Vaccine Against Influenza and COVID-19 in Healthy Adults.
Journal: Vaccines
Published: July 02, 2026
Similar Doctors
Expertise in
15
conditions
Dr. Sheri Y. Chinen
Endocrinology
Expertise in
15
conditions
Dr. Sheri Y. Chinen
Endocrinology
Referral required
Before you request

Straub Medical Center

888 S King St, 
Honolulu, HI 
 (0.7 miles away)
808-522-4344
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sheri Chinen is an Endocrinologist practicing medicine in Honolulu, Hawaii. Dr. Chinen is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Graves Disease, Thyroid Storm, Hyperparathyroidism, and Osteitis Fibrosa. Dr. Chinen is currently accepting new patients.

Expertise in
24
conditions
Dr. Frank D. Singer
Endocrinology
Expertise in
24
conditions
Dr. Frank D. Singer
Endocrinology
Referral required
Before you request

Pali Momi Medical Center

98-1079 Moanalua Road, Suite 600, 
Aiea, HI 
 (8.5 miles away)
808-522-4344
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Frank Singer is an Endocrinologist practicing medicine in Aiea, Hawaii. Dr. Singer is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Type 2 Diabetes (T2D), and Graves Disease. Dr. Singer is currently accepting new patients.

Expertise in
5
conditions
Dr. Chanhaeng Rhee
Endocrinology
Expertise in
5
conditions
Dr. Chanhaeng Rhee
Endocrinology
Referral required
Before you request

The Queen′s Health Systems - Manamana - Physicians Office Building 3

550 S. Beretania Street, Suite 202, 
Honolulu, HI 
 (1.0 miles away)
808-691-8526
Languages Spoken:
English, Japanese, Korean
See accepted insurances
Accepting New Patients
Offers Telehealth

Chanhaeng Rhee is an Endocrinologist practicing medicine in Honolulu, Hawaii. Dr. Rhee is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Diabetic Neuropathy, and Diabetic Nephropathy. Dr. Rhee is currently accepting new patients.

Frequently Asked Questions about Dr. David Fitz-Patrick

How do I make an appointment with Dr. David Fitz-Patrick?

You can book an appointment with Dr. David Fitz-Patrick by calling their office at 808-531-6886. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David Fitz-Patrick a top-rated expert for Maturity Onset Diabetes of the Young?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David Fitz-Patrick is classified as an Advanced expert for Maturity Onset Diabetes of the Young, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David Fitz-Patrick specialize in?

While Dr. David Fitz-Patrick is a Endocrinology, they have specific expertise in Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), and Prolactinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. David Fitz-Patrick participate in research or clinical trials?

Yes. Dr. David Fitz-Patrick has published 19 articles and abstracts on conditions like Maturity Onset Diabetes of the Young. You can view a list of Dr. David Fitz-Patrick's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David Fitz-Patrick accept my insurance?

Dr. David Fitz-Patrick accepts most major insurance plans, including Aetna and AlohaCare. We recommend calling the office directly at 808-531-6886 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fitz-Patrick's expertise for a condition
ConditionClose
      View All 38 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile